Chairs
- G. Jerusalem (Liège, Belgium)
Welcome and introduction (ID 345)
Lecture Time
17:30 - 17:35
Speakers
- G. Jerusalem (Liège, Belgium)
From clinical trials to real-world effectiveness: Charting a new standard in HR+/HER2- breast cancer (ID 346)
Lecture Time
17:35 - 18:00
Speakers
- D. Patt (Austin, TX, United States of America)
The route to a new reality: Treatment considerations for gBRCA-mutated aBC (ID 348)
Lecture Time
18:00 - 18:15
Speakers
- M. Lux (Paderborn, Germany)
Q&A discussion (ID 347)
Lecture Time
18:15 - 18:30
Speakers
- A. Speakers (, Switzerland)